ArticleDalton transactions (Cambridge, England : 2003)2011
Multimodality and nanoparticles in medical imaging.
Article in Dalton transactions (Cambridge, England : 2003), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 92 citations in OpenAlex.
- Magnetic Resonance Imaging and X-Ray Imaging Properties of Ultrasmall Lanthanide Oxide (Ln = Eu, Gd, and Tb) Nanoparticles Synthesized via Thermal Decomposition.Molecules (Basel, Switzerland) · 2025Article
- Innovative applications of advanced nanomaterials in cerebrovascular imaging.Frontiers in bioengineering and biotechnology · 2024Review
- Polymer-Based Nanosystems-A Versatile Delivery Approach.Materials (Basel, Switzerland) · 2021Review
- The Pharmaceutical Technology Approach on Imaging Innovations from Italian Research.Pharmaceutics · 2021Review
- Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics.International journal of molecular sciences · 2021Review
- Magnetic Nanoparticle Composites: Synergistic Effects and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021Review
- Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.Molecules (Basel, Switzerland) · 2021Review
- Mitochondriotropic lanthanide nanorods: implications for multimodal imaging.Chemical communications (Cambridge, England) · 2020Article
- Supramolecular and biomacromolecular enhancement of metal-free magnetic resonance imaging contrast agents.Chemical science · 2020Article
- Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.International journal of nanomedicine · 2020Article
- Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging.ACS omega · 2019Article
- Structure-Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging.Advanced materials (Deerfield Beach, Fla.) · 2019Review
- Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides.Frontiers in medicine · 2015Article
- Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.Pharmaceutical research · 2014Article
- Vivid tumor imaging utilizing liposome-carried bimodal radiotracer.ACS medicinal chemistry letters · 2014Article
- Environmentally responsive MRI contrast agents.Chemical communications (Cambridge, England) · 2013Review
- High signal contrast gating with biomodified Gd doped mesoporous nanoparticles.Chemical communications (Cambridge, England) · 2013Article
- Grand challenges in inorganic chemistry: toward better life quality and a more sustainable world.Frontiers in chemistry · 2013Article
- Location-tuned relaxivity in Gd-doped mesoporous silica nanoparticles.Journal of materials chemistry · 2012Article
- Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Radiochimica acta · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
A number of medical imaging techniques are used heavily in the provision of spatially resolved information on disease and physiological status and accordingly play a critical role in clinical diagnostics and subsequent treatment. Though, for most imaging modes, contrast is potentially enhanced through the use of contrast agents or improved hardware or imaging protocols, no single methodology provides, in isolation, a detailed mapping of anatomy, disease markers or physiological status. In recent years, the concept of complementing the strengths of one imaging modality with those of another has come to the fore and been further bolstered by the development of fused instruments such as PET/CT and PET/MRI stations. Coupled with the continual development in imaging hardware has been a surge in reports of contrast agents bearing multiple functionality, potentially providing not only a powerful and highly sensitised means of co-localising physiological/disease status and anatomy, but also the tracking and delineation of multiple markers and indeed subsequent or simultaneous highly localized therapy ("theragnostics").
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.